Healthcare & Life Sciences: Drug Pricing Digest - May 2021 #2

PhRMA Suit Challenges Co-Pay/Accumulator Portion of December 2020 Medicaid Rule -

On May 21, 2021, Pharmaceutical Research and Manufacturers of America (PhRMA) filed suit in the US District Court for the District of Columbia, challenging the portions of the December 2020 Medicaid final rule related to the price reporting treatment of manufacturer-sponsored patient co-pay assistance programs when the patient’s health plan has implemented a so-called “accumulator adjustment program.” PhRMA explains that the final rule “treats financial assistance manufacturers provide to patients as if such assistance were a price discount that the manufacturer instead provided to the patients’ health plans, unless the manufacturer somehow ‘ensures’ that no health plan retroactively takes the benefits that the manufacturer intended for and provided to patients through the imposition of an accumulator adjustment program,” which PhRMA asserts “contradicts the Medicaid rebate statute’s plain text.” The case is Pharmaceutical Research and Manufacturers of America v. Becerra, No. 1:21-cv-01395 (D.D.C. filed May 21, 2021).

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.